EKF Diagnostics Holdings plc (AIM:EKF)
London · Delayed Price · Currency is GBP · Price in GBX 27.45
+0.05 (0.18%)
At close: Jan 22, 2026
EKF Diagnostics Holdings Market Cap
EKF Diagnostics Holdings has a market cap or net worth of 118.53 million as of January 22, 2026. Its market cap has decreased by -3.25% in one year.
Market Cap
118.53M
Enterprise Value
104.18M
Revenue
50.22M
Ranking
n/a
PE Ratio
20.28
Stock Price
27.45
Market Cap Chart
Since June 30, 2003, EKF Diagnostics Holdings's market cap has increased from 2.27M to 118.53M, an increase of 5,113.37%. That is a compound annual growth rate of 19.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 118.53M | 3.46% |
| Dec 31, 2025 | 114.57M | -6.48% |
| Dec 31, 2024 | 122.51M | -14.69% |
| Dec 29, 2023 | 143.61M | -36.87% |
| Dec 30, 2022 | 227.47M | -34.63% |
| Dec 31, 2021 | 347.95M | 6.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 209.68B |
| GSK plc | 72.04B |
| Haleon | 32.16B |
| Smith & Nephew | 10.20B |
| Animalcare Group | 175.38M |
| Animalcare Group | 175.38M |
| Diaceutics | 135.01M |
| Scancell Holdings | 134.91M |